We assumed that upregulated CKS2 might reshape the tumor microenvironment of endometrial carcinoma by means of inhibiting the population of B cells and CD4+ T cells or increasing the population of neutrophils to contribute to the initiation and progression of endometrial carcinoma. The gene discussed is CD4; the disease is neoplasm.